KEGG: eic:NT01EI_3153
STRING: 634503.NT01EI_3153
GMP synthase [glutamine-hydrolyzing] (guaA) is an enzyme encoded by the guaA gene in Edwardsiella ictaluri, a gram-negative fish pathogen that causes enteric septicemia in catfish . This enzyme belongs to the glutamine amidotransferase family, which catalyzes the amination of various molecules using the amide nitrogen from glutamine . Specifically, GMP synthase catalyzes the final step in GMP biosynthesis, converting XMP (xanthosine monophosphate) to GMP (guanosine monophosphate) using ATP and glutamine as substrates. The enzyme demonstrates complex multi-active-site regulation and interdomain communication typical of glutamine amidotransferases .
E. ictaluri GMP synthase likely shares structural features with other bacterial GMP synthases, particularly those from E. coli which have been more extensively studied. The enzyme contains multiple tryptophan residues dispersed throughout its structure that are critical for monitoring conformational changes . Like other GMP synthases, it likely possesses two main functional domains: a glutaminase domain that hydrolyzes glutamine to generate ammonia, and a synthetase domain that uses this ammonia to aminate XMP, forming GMP. The study of GMP synthase from other organisms has shown that it undergoes significant conformational changes upon binding of its nucleotide substrates, suggesting a complex tertiary structure with dynamic properties essential for its catalytic function .
GMP synthase plays a central role in purine nucleotide biosynthesis, which is essential for the growth and survival of E. ictaluri. While not specifically identified among the documented virulence genes (citC, gadB, katB, mukF, and fimA) , GMP synthase likely contributes indirectly to pathogenicity by enabling bacterial replication within host tissues. As E. ictaluri is described as a "nasal/oral invasive intracellular pathogen" , its ability to proliferate inside host cells would depend on robust nucleotide synthesis pathways. The essential nature of guaA makes it a potential target for vaccine development strategies, similar to the balanced-lethal system developed with the asdA gene in E. ictaluri for recombinant attenuated Edwardsiella vaccines (RAEV) .
Recombinant E. ictaluri GMP synthase can be expressed in multiple host systems, each offering distinct advantages for different research purposes:
| Expression System | Advantages | Disadvantages | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | Limited post-translational modifications | Structural studies, enzymatic assays |
| Yeast | Better protein folding, some post-translational modifications | Lower yield than E. coli | Functional studies requiring proper folding |
| Baculovirus | High expression levels, advanced modifications | More complex, time-consuming | Complex protein expression, activity studies |
| Mammalian Cell | Most authentic post-translational modifications | Highest cost, lowest yield | Studies requiring native-like enzyme |
According to product specifications, recombinant preparations can achieve "greater or equal to 85% purity as determined by SDS-PAGE" regardless of the expression system used .
Stopped-flow tryptophan fluorescence spectroscopy provides valuable insights into the conformational dynamics of GMP synthase. This technique reveals that the enzyme undergoes significant conformational changes upon binding its nucleotide substrates . When GMP synthase (premixed with ATP) is combined with XMP substrate, a decay in intrinsic tryptophan fluorescence occurs, indicating alteration in the environment of one or more of the enzyme's tryptophan residues . The conformational change appears sequential, with an initial lag phase (<10ms) that decreases with increasing substrate concentration, followed by a decay phase representing the actual conformational adjustment . This methodology could be applied to studying E. ictaluri GMP synthase by:
Monitoring intrinsic tryptophan fluorescence changes upon substrate binding
Creating tryptophan-to-phenylalanine mutants to identify specific residues involved in conformational changes
Analyzing the kinetics of these changes to determine rate constants for binding and conformational change steps
The adenylylated XMP intermediate formed during the GMP synthase reaction can be isolated and characterized using several approaches:
HPLC separation: Mixing GMP synthase with ATP and XMP substrates (without glutamine) leads to the formation of a distinct peak in HPLC analysis corresponding to the adenylylated XMP intermediate .
Verification through substrate addition: The identity of this intermediate can be confirmed by adding glutamine to the reaction mixture, which causes the intermediate peak to disappear concomitant with the appearance of the GMP product peak .
Scale-up preparation: Large-scale enzyme preparation facilitates isolation of sufficient intermediate for detailed spectral analysis .
Stability analysis: The enzyme-bound adenylylated XMP intermediate is stable enough to be separated and analyzed, making it accessible for characterization studies .
This intermediate represents a crucial step in understanding the catalytic mechanism and conformational dynamics of GMP synthase.
Site-directed mutagenesis provides a powerful approach for investigating structure-function relationships in E. ictaluri GMP synthase. Based on experimental methods described for other GMP synthases, researchers can implement the following protocol:
Tryptophan-to-phenylalanine mutations:
Target selection strategies:
Identify conserved residues through sequence alignment with characterized GMP synthases
Focus on residues in predicted catalytic sites or domain interfaces
Create systematic mutations of tryptophan residues to map conformational changes
Design mutations to probe substrate specificity and catalytic efficiency
Functional analysis of mutants:
Measure enzymatic activity using HPLC detection of GMP formation
Analyze fluorescence changes upon substrate binding
Determine the impact on intermediate formation and stability
This approach allows systematic mapping of residues critical for substrate binding, catalysis, and interdomain communication.
Interdomain communication in GMP synthase is crucial for coordinating the glutaminase and synthetase activities. Several experimental approaches can investigate this phenomenon:
Domain-specific mutations:
Introduce mutations at predicted domain interfaces
Create chimeric enzymes with domains from different species
Analyze the impact on catalytic activity and conformational changes
Biophysical characterization:
Structural analysis:
X-ray crystallography or cryo-EM to capture different conformational states
Compare structures with and without bound substrates or intermediates
Molecular dynamics simulations to model domain movements and communication pathways
These approaches can reveal how substrate binding in one domain triggers conformational changes that activate the other domain, a critical aspect of GMP synthase's catalytic mechanism.
Assessment of environmental factors on GMP synthase activity is particularly relevant given E. ictaluri's role as a fish pathogen. A comprehensive experimental design would include:
Temperature-dependent activity:
Measure enzyme activity across a range of temperatures relevant to fish hosts
Determine temperature optima and compare with the typical temperature range of catfish environments
Analyze thermal stability through differential scanning fluorimetry
pH dependence:
Evaluate activity across pH ranges encountered during infection (gut, tissue, intracellular environments)
Measure conformational changes at different pH values using tryptophan fluorescence
Assess stability and folding at various pH conditions
Ion effects:
Determine the impact of varying Mg²⁺ concentrations (required for ATP binding)
Investigate effects of other physiologically relevant ions (K⁺, Na⁺, Ca²⁺)
Analyze salt tolerance relevant to freshwater versus brackish environments
Oxidative stress response:
Measure activity in the presence of reactive oxygen species encountered during host immune response
Identify potential redox-sensitive residues through targeted mutagenesis
Evaluate protective mechanisms against oxidative inactivation
E. ictaluri GMP synthase could be leveraged for vaccine development through several strategic approaches:
Balanced-lethal complementation system:
Attenuated vaccine strain development:
Antigen delivery platform:
This approach builds upon the successful balanced-lethal system already demonstrated in E. ictaluri, which represents "the first step to develop an antibiotic-sensitive RAEV for the aquaculture industry" .
Comparative analysis of GMP synthase across Edwardsiella species could provide valuable insights into evolutionary relationships and functional adaptations:
Phylogenetic analysis:
Structure-function relationships:
Map sequence variations onto structural models to identify potentially functionally significant differences
Correlate sequence variations with differences in host range or virulence
Compare with GMP synthases from other bacterial pathogens to identify convergent evolution
Selective pressure analysis:
Calculate dN/dS ratios to identify regions under positive or purifying selection
Correlate with host shifts or environmental adaptations
Compare with other metabolic genes to determine if guaA is evolving at similar rates
Structural insights into E. ictaluri GMP synthase can guide rational inhibitor design for potential therapeutic applications:
Active site mapping:
Transition state analysis:
Determine the structure of transition state analogs bound to the enzyme
Identify stabilizing interactions that could be exploited for inhibitor design
Develop transition state mimics as potential high-affinity inhibitors
Allosteric site identification:
Species-specific targeting:
Compare E. ictaluri GMP synthase with host (fish) GMP synthase
Identify structural differences that could be exploited for selective inhibition
Design inhibitors that preferentially target bacterial over host enzyme
These approaches could lead to novel therapeutics for controlling enteric septicemia in catfish aquaculture, addressing a significant economic challenge in the industry.
CRISPR-Cas9 genome editing offers powerful approaches for studying E. ictaluri GMP synthase:
Precise gene modifications:
Create clean knockouts of guaA to study essentiality and phenotypic consequences
Introduce point mutations to study specific amino acid functions in vivo
Tag the endogenous enzyme with reporters for localization studies
Regulatable expression systems:
Engineer inducible/repressible guaA expression to study dose-dependent effects
Create conditional lethal strains for vaccine development
Implement CRISPRi for partial knockdown to identify threshold activity requirements
High-throughput functional genomics:
Create CRISPR libraries targeting guaA regulatory elements
Screen for synthetic lethality with other metabolic genes
Identify genetic interactions through combinatorial targeting
These approaches would complement traditional methods and could accelerate both basic research and applied vaccine development for E. ictaluri.
Synthetic biology offers innovative strategies for harnessing E. ictaluri GMP synthase:
Engineered enzyme variants:
Design synthetic GMP synthases with enhanced catalytic efficiency
Create thermostable variants for industrial applications
Develop substrate specificity alterations for novel nucleotide analog production
Modular vaccine platforms:
Construct standardized balanced-lethal expression cassettes based on guaA
Develop plug-and-play antigen expression systems for rapid vaccine prototyping
Engineer strains with programmable attenuation profiles
Biosensor development:
Create GMP synthase-based biosensors for detecting nucleotide precursors
Develop reporter systems for monitoring bacterial metabolism in vivo
Design diagnostic tools for monitoring E. ictaluri infection in aquaculture
These synthetic biology applications could transform both research tools and practical applications in aquaculture disease management.
Understanding GMP synthase within the context of broader bacterial metabolism requires integrative approaches:
Systems biology analysis:
Map metabolic flux through purine biosynthesis pathways
Identify regulatory connections between nucleotide metabolism and other pathways
Model the impact of environmental changes on metabolic network functioning
Multi-omics integration:
Correlate transcriptomic data on guaA expression with metabolomic profiles
Link proteomic analysis of GMP synthase abundance with pathway activity
Identify post-translational modifications affecting enzyme activity
Host-pathogen interface:
Study how host metabolites affect bacterial GMP synthase activity
Analyze competition for nucleotide precursors between host and pathogen
Identify metabolic bottlenecks during infection that could be therapeutic targets
This integrative perspective would place GMP synthase research in a broader biological context, potentially revealing unexpected connections and novel intervention strategies for controlling E. ictaluri infections in aquaculture.